HK Stock MarketDetailed Quotes
01931 IVD MEDICAL
- 2.110
- +0.100+4.98%
Market Closed Oct 16 16:08 CST
3.43BMarket Cap11.99P/E (TTM)
2.160High2.100Low232.00KVolume2.120Open2.010Pre Close493.17KTurnover0.01%Turnover Ratio13.02P/E (Static)1.63BShares2.89052wk High0.92P/B3.43BFloat Cap0.62052wk Low0.05Dividend TTM1.63BShs Float4.053Historical High0.077Dividend LFY2.99%Amplitude0.620Historical Low2.125Avg Price1000Lot Size2.46%Div YieldTTM3.65%Div Yield LFY
IVD MEDICAL Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -1.73%1.35B | 12.35%3.09B | 17.06%1.38B | 0.66%2.75B | -0.86%1.18B | 12.46%2.73B | 20.95%1.19B | 4.09%2.43B | 7.50%981.24M | 463.96%2.33B |
| Operating income | -1.73%1.35B | 12.35%3.09B | 17.06%1.38B | 0.66%2.75B | -0.86%1.18B | 12.46%2.73B | 20.95%1.19B | 4.09%2.43B | 7.50%981.24M | 463.96%2.33B |
| Cost of sales | 4.37%-1.03B | -12.89%-2.42B | -18.20%-1.08B | 1.10%-2.14B | 3.88%-910.13M | -10.88%-2.16B | -20.31%-946.9M | -3.29%-1.95B | -12.82%-787.06M | -536.39%-1.89B |
| Operating expenses | 4.37%-1.03B | -12.89%-2.42B | -18.20%-1.08B | 1.10%-2.14B | 3.88%-910.13M | -10.88%-2.16B | -20.31%-946.9M | -3.29%-1.95B | -12.82%-787.06M | -536.39%-1.89B |
| Gross profit | 7.68%324.69M | 10.45%671.7M | 13.18%301.54M | 7.39%608.14M | 11.06%266.42M | 18.92%566.27M | 23.54%239.89M | 7.52%476.17M | -9.75%194.18M | 279.60%442.88M |
| Selling expenses | 0.79%-60.09M | -16.27%-136.31M | -31.67%-60.57M | 4.35%-117.24M | 0.60%-46M | -15.98%-122.57M | -15.94%-46.28M | -9.38%-105.68M | -17.37%-39.92M | -730.71%-96.62M |
| Administrative expenses | -5.89%-76.17M | -4.62%-159.98M | 7.06%-71.93M | 16.83%-152.92M | 2.27%-77.4M | -27.59%-183.85M | 7.70%-79.19M | -15.57%-144.09M | -106.66%-85.8M | -127.94%-124.68M |
| Revaluation surplus | 99.64%-6K | -80.10%-20.63M | 76.39%-1.65M | -182.30%-11.46M | -4,206.47%-6.98M | 206.43%13.92M | -55.96%170K | --4.54M | --386K | ---- |
| -Changes in the fair value of financial assets | 99.64%-6K | -80.10%-20.63M | 76.39%-1.65M | -182.30%-11.46M | -4,206.47%-6.98M | 206.43%13.92M | -55.96%170K | --4.54M | --386K | ---- |
| Impairment and provision | -715.22%-566K | ---- | --92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -715.22%-566K | ---- | --92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | 31.20%-21.04M | ---- | -49.74%-30.58M | -33.46%-11.91M | 13.99%-20.42M | 28.11%-8.93M | -205.05%-23.75M | -278.97%-12.42M | ---7.78M |
| Special items of operating profit | -56.86%8.18M | 322.58%27.29M | 193.00%18.96M | -273.71%-12.26M | -242.79%-20.38M | -69.98%7.06M | 108.35%14.28M | -70.98%23.52M | 61.64%6.85M | 1,271.98%81.05M |
| Operating profit | 5.15%196.04M | 27.26%361.03M | 79.70%186.44M | 8.94%283.69M | -13.50%103.75M | 12.87%260.41M | 89.53%119.94M | -21.75%230.71M | -54.99%63.28M | 578.94%294.85M |
| Financing cost | -8.29%-11.63M | ---- | ---10.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | 70.09%-3.63M | -3,501.41%-16.84M | -2,262.03%-12.13M | -27.53%495K | 96.84%561K | 6.39%683K | 51.60%285K | -73.01%642K | -96.33%188K | -96.89%2.38M |
| Share of profit from joint venture company | 56.11%-291K | -353.13%-5.82M | -206.94%-663K | -69.94%2.3M | -21,500.00%-216K | 11,872.31%7.65M | ---1K | ---65K | ---- | ---- |
| Special items of earning before tax | ---- | 135.56%958K | ---- | -236.75%-2.69M | 52.41%-603K | -219.58%-800K | 59.36%-1.27M | 329.90%669K | -101.61%-3.12M | 87.54%-291K |
| Earning before tax | 10.79%180.49M | 19.57%339.33M | 57.41%162.91M | 5.92%283.79M | -13.00%103.5M | 15.51%267.94M | 97.10%118.96M | -21.88%231.96M | -82.22%60.35M | 152.45%296.94M |
| Tax | 10.15%-52.93M | -15.80%-102.2M | -74.31%-58.91M | 16.89%-88.26M | 18.76%-33.79M | -37.31%-106.19M | -71.46%-41.6M | -83.61%-77.34M | 44.68%-24.26M | -132.53%-42.12M |
| After-tax profit from continuing operations | 22.66%127.57M | 21.27%237.13M | 49.21%104M | 20.88%195.53M | -9.90%69.7M | 4.61%161.75M | 114.34%77.36M | -39.32%154.62M | -87.79%36.09M | 156.08%254.82M |
| Earning after tax | 22.66%127.57M | 21.27%237.13M | 49.21%104M | 20.88%195.53M | -9.90%69.7M | 4.61%161.75M | 114.34%77.36M | -39.32%154.62M | -87.79%36.09M | 156.08%254.82M |
| Minority profit | 129.41%2.28M | 92.83%-1.04M | 108.67%993K | -13.12%-14.47M | -650.20%-11.45M | -211.98%-12.79M | 30.29%-1.53M | 79.68%-4.1M | 22.84%-2.19M | -413.28%-20.18M |
| Profit attributable to shareholders | 21.63%125.29M | 13.41%238.16M | 26.94%103.01M | 20.31%210M | 2.87%81.15M | 9.97%174.54M | 106.07%78.89M | -42.28%158.72M | -87.18%38.28M | 165.86%275M |
| Basic earnings per share | 21.65%0.0927 | 12.88%0.1762 | 25.54%0.0762 | 18.35%0.1561 | 1.85%0.0607 | 10.56%0.1319 | 107.67%0.0596 | -50.80%0.1193 | -90.87%0.0287 | 44.78%0.2425 |
| Diluted earnings per share | 21.65%0.0927 | 13.68%0.1762 | 27.42%0.0762 | 19.78%0.155 | 1.70%0.0598 | 9.11%0.1294 | 105.59%0.0588 | -44.79%0.1186 | -90.91%0.0286 | 28.24%0.2148 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data